Results 81 to 90 of about 234,929 (313)

The 9+ month marathon: How pregnancy may have shaped human endurance capacities

open access: yesThe Anatomical Record, EarlyView.
Abstract Anthropology has long considered the evolution of our uniquely human endurance capacities to be the result of selection upon anatomical and physiological features imposed by the demands of thermoregulation and resource acquisition, particularly during the demands of persistence hunting. Research has focused on the anatomical changes present in
Cara Ocobock
wiley   +1 more source

First trimester pre‐eclampsia screening and maternal left ventricular geometry

open access: yes
Objective: Pre-eclampsia (PE) is a pregnancy complication associated with premature cardiovascular disease morbidity and mortality (i.e. before 60 years of age or in the first year postpartum).
O'Driscoll, J.   +3 more
core   +1 more source

ADAM12 and first trimester trisomy screening [PDF]

open access: yes
The purpose of this study was to evaluate the efficacy of adding a new marker, a disintegrin and metalloproteinase domain 12 (ADAM12), in the first trimester screening programme for chromosomal disorders in singleton pregnancies in the general Finnish ...
Valinen, Yrtti
core   +1 more source

Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test [PDF]

open access: yes, 2018
Objective: To report on the routine clinical implementation of cell-free (cf)DNA analysis of maternal blood for trisomies 21, 18 and 13 contingent on the results of the first-trimester combined test in twin pregnancies.
Gil Mira, María del Mar   +9 more
core   +1 more source

Nationwide Temporal Trends in Adverse Pregnancy Outcomes and Treatments in Systemic Lupus Erythematosus Pregnancy Over Two Decades in Sweden

open access: yesArthritis &Rheumatology, EarlyView.
Objective This nationwide descriptive study examined temporal trends in adverse pregnancy outcomes (APOs) and treatments in systemic lupus erythematosus (SLE) pregnancies in Sweden over 2003 to 2022. Methods Using nationwide Swedish registers, we identified 1,417 pregnancies of women with prevalent SLE and delivery dates in 2003 to 2022 and matched ...
Ngoc V. Nguyen   +6 more
wiley   +1 more source

Assessing the psychological impact and acceptability of a first-trimester screening test for pre-eclampsia

open access: yes, 2015
BACKGROUND: A first-trimester prenatal screening test for pre-eclampsia was launched in 2010. It differs from previously assessed prenatal screening tests.
Harris, JM
core  

Clinical Importance of the First Trimester Uterine Artery Doppler Measurements in Patients with Hyperemesis Gravidarum

open access: yes
Objective: To examine the relationship between the first trimester uterine artery doppler measurements, biochemical markers, first trimester antenatal screening test and severity of hyperemesis gravidarum (HG) according to Pregnancy-Unique Quantification
Esra KELEŞ   +8 more
core   +1 more source

Increased Risk of Intrahepatic Cholestasis of Pregnancy in Women With Systemic Lupus Erythematosus Exposed to Azathioprine

open access: yesArthritis &Rheumatology, EarlyView.
Objective To evaluate the risk of intrahepatic cholestasis of pregnancy (ICP) in azathioprine (AZA)–exposed versus unexposed systemic lupus erythematosus (SLE) pregnancies within the multicenter prospective Lupus in Pregnancy (LEGACY) cohort. Methods LEGACY is conducted at Systemic Lupus International Collaborating Clinics in Canada, South Korea, Peru,
Reem Farhat   +14 more
wiley   +1 more source

Diagnosis of Acute Toxoplasmosis in the First Trimester of Pregnancy by IgG Avidity

open access: yesپزشکی بالینی ابن سینا, 2022
Background and Objective: The most important concern associated with diagnosing congenital toxoplasmosis is to determine when the mother has been infected.
Afshin Azimi   +4 more
doaj  

Zuranolone: A case study in (regulatory) rush to judgement?

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy